Prof. Hossam Haick

Prof. Hossam Haick is a Full Professor at the Technion – Israel Institute of Technology, where he also serves as the Dean of Undergraduate Studies. He earned his Ph.D. in Chemical Engineering from the Technion in 2002, followed by two postdoctoral fellowships—first at the Weizmann Institute of Science and later at the California Institute of Technology (Caltech). He rejoined the Technion in 2006 as an Assistant Professor and achieved the rank of Full Professor in 2011.

Prof. Haick is internationally recognized as an expert in nanotechnology and non-invasive disease diagnosis. His pioneering work includes the development of nano-array devices for screening, diagnosis, and disease monitoring, nanomaterial-based flexible sensors, electronic skin, breath analysis, and volatile biomarkers. He has published two notable books: Nature Inspired Sensors (Elsevier, 2024) and Volatile Biomarkers for Human Health: From Nature to Artificial Senses (Royal Society of Chemistry, 2022). His research has produced over 420 peer-reviewed publications in leading journals across nanotechnology, advanced materials, and clinical medicine, along with multiple book chapters. As of 2024, his work has accumulated approximately 30,000 citations, with an H-index of 91. The innovations from Prof. Haick’s research group have led to over 52 patents and patent applications, with many licensed to international companies. Additionally, he has co-founded five startups, commercializing ground-breaking sensing technologies.

Prof. Haick has served as the coordinator of several significant EU-funded projects, including VOLABIOS (Horizon Europe, RIA), LUCIA (Horizon Europe, Cancer Mission), A-Patch (Horizon 2020, ICT), SNIFFPHONE (Horizon 2020, ICT), VOGAS (Horizon 2020, CELAC), VOLGACORE (EuroNanoMed-II), LCAOS (FP7, Health Program), and DIAG-CANCER (FP7, Health Program). These projects have been instrumental in advancing medical diagnostics, wearable sensing technologies, and early disease detection. Across these initiatives, Prof. Haick has led multidisciplinary consortia comprising a total of over 72 partners from academia, industry, and the public sector. These collaborative projects have catalyzed the development of innovative technologies and facilitated their transition into practical applications, particularly in healthcare and diagnostics, impacting clinical practices and industry standards.

Prof. Haick’s contributions have been acknowledged with numerous prestigious awards, including the Diane Sherman Prize for Medical Innovations, the Zimin Prize for AI Solutions in Healthcare, and the Bruno Prize, etc. He has received the Humboldt Senior Research Award and an Honorary Doctorate from the University of Haifa. Prof. Haick was also honored as a Knight of the Order of Academic Palms, conferred by the French Government in 2010. Additionally, he has been listed in influential rankings such as the world’s 35 leading young scientists by MIT Technology Review (2008) and the top 100 innovators globally from 2015 to 2018.

Prof. Haick’s dedication to education and societal impact is evident through his development of a widely recognized Massive Open Online Course (MOOC) on Nanotechnology and Nanosensors. Launched in 2013 through Coursera, this course is offered in both English and Arabic and has attracted over one million learners from 87 countries. The course emphasizes accessibility, collaborative learning, and global inclusivity. Over 70,000 final projects have been developed by learners worldwide, fostering a diverse community of future scientists and innovators.

Beyond his academic contributions, Prof. Haick actively bridges the gap between science and application, leading one of the largest clinical studies in non-invasive diagnostics across 40+ global centers. His AI-driven, wearable sensors detect over dozen of diseases, enabling early diagnosis and improved outcomes. He collaborates with the Bill & Melinda Gates Foundation, the European Commission, and WHO to develop wearable health solutions for underserved populations, focusing on accessible healthcare in remote regions lacking infrastructure.